Delivery Order SPE2DB22D7065-SPE2DB23FH2FG

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,557 to Amerisourcebergen Drug Corporation for 30 entecavir 0.5 mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 14, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand three hundred ninety-two dollars and sixty-four cents ($12,392.64) to Amerisourcebergen Drug Corporation for entecavir 0.5 mg tablets. Under the contract, Amerisourcebergen will deliver thirty (30) boxes of entecavir tablets to a facility in Conshohocken, Pennsylvania by September 8, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen Drug Corporation, a division of...
The Defense Logistics Agency awarded a $1,979.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 entecavir 0.5 mg tablets to be delivered to a location in Conshohocken, Pennsylvania within a one day period from September 7-8, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this small business set-aside contract to supply pharmaceutical products in support of the Defense Logistics Agency's...
The Defense Logistics Agency Troop Support Medical awarded a $7,242.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561436887 entecavir 0.5 mg tablets (30 count). Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support the Agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,810.25 contract is for the delivery of Entecavir 0.5 mg tablets to support DLA Troop Support Medical operations. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals and medical supplies to the Department of Defense under similar firm...
The Defense Logistics Agency awarded a $989.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 0.5 mg entecavir to be delivered to a facility in Conshohocken, Pennsylvania. The delivery order was issued under an existing prime vendor contract vehicle and calls for shipment of the pharmaceutical product between July 28 and July 31, 2023 to support the Department of Defense's medical supply needs. No set aside designation or subcontractors were identified.
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,665.69 to Amerisourcebergen Drug Corporation for the supply of 4561485885 entecavir 0.5 mg tablets (30 count). As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 14, 2023 to support the Defense Logistics Agency's medical supply needs. No additional subcontractors or set aside designations were identified in...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $3,286.83 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 30 entecavir 0.5 mg tablets with a completion date of November 24, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its headquarters in Conshohocken, Pennsylvania in support of DLA's provision of medical supplies and medications to military treatment facilities. Amerisourcebergen...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB23FH2FG
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,637 to Amerisourcebergen Drug Corporation to supply 30 tablets of 0.5 mg entecavir. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the contract starting on September 13, 2023 through September 14, 2023. No set aside provisions or subcontracting arrangements were identified in the award provided to Amerisourcebergen Drug Corporation by the DLA to support its medical supply chain needs.

Generated 12/19/23, 10:59 PM